share_log

Barclays Maintains Overweight on IDEXX Laboratories, Raises Price Target to $592

Benzinga ·  Nov 2, 2023 11:21

Barclays analyst Balaji Prasad maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and raises the price target from $590 to $592.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment